A review of quality measures for assessing the impact of antimicrobial stewardship programs in hospitals

Antibiotics

Volumn 5, Issue 1, 2016, Pages

  Akpan, Mary Richard ^a   Ahmad, Raheelah ^b   Shebl, Nada Atef ^a   Ashiru Oredope, Diane ^c  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antimicrobial resistance; Antimicrobial stewardship; Infectious diseases; Outcome; Patient; Quality indicators

Indexed keywords

CEFTAZIDIME;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP PROGRAM; CLOSTRIDIUM DIFFICILE INFECTION; DRUG COST; DRUG UTILIZATION; HOSPITAL; HOSPITAL READMISSION; HUMAN; INFORMATION PROCESSING; LENGTH OF STAY; MEDICAL AUDIT; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRAM EVALUATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 85012874889     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics5010005     Document Type: Review

References (88)

1. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance; World Health Organization: Geneva, Switzerland, 2014.
2. Department of Health. English Surveillance Program Antimicrobial Utilization and Resistance (ESPAUR) Report; Department of Health: London, UK, 2014.
3. European Centre for Disease Prevention and Control. Antimicrobial Resistance Surveillance in Europe; European Centre for Disease Prevention and Control: London, UK, 2013.
4. Dellit, T.; Owens, R.; McGowan, J.; Gerding, D.; Weinstein, R.; Burke, J.; Huskin, W.; Paterson, D.; Fishman, N.; Carpenter, C.; et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiologyof America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 2007, 44, 159-177.
5. Tamma, P. D.; Holmes, A.; Ashley, E. Antimicrobial stewardship: Another focus for patient safety? Curr. Opin. Infect. Dis. 2014, 27, 348-355. [CrossRef] [PubMed].
6. Goossens, H.; French, M.; vander Stichele, R.; Elseviers, M.; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005, 365, 579-587. [CrossRef].
7. Aldeyab, M.; Harbarth, S.; Vernaz, N.; Kearney, M.; Scott, M.; Darwish Elhajji, F.; Aldiab, M.; McElnay, J. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br. J. Clin. Pharmacol. 2012, 74, 171-179. [CrossRef] [PubMed].
8. Livermore, D.; Hope, R.; Reynolds, R.; Blackburn, R.; Johnson, A.; Woodford, N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: Links to prescribing change? J. Antimicrob. Chemother. 2013, 68, 2667-2674. [CrossRef] [PubMed].
9. Doron, S.; Davidson, L. E. Antimicrobial stewardship. Mayo Clin. Proc. 2011, 86, 1113-1123. [CrossRef] [PubMed].
10. Owens, R., Jr. Antimicrobial stewardship: Concepts and strategies in the 21st century. Diagn. Microbiol. Infect. Dis. 2008, 61, 110-128. [CrossRef] [PubMed].
11. Davey, P.; Brown, E.; Charani, E.; Fenelon, L.; Gould, I.; Holmes, A.; Ramsay, C.; Wiffen, P.; Wilcox, M. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst. Rev. 2013, CD003543. [CrossRef].
12. Public Health England. Antimicrobial Stewardship: "Start Smart-Then Focus"; Public Health England: London, UK, 2015.
13. National Institute for Health and Care Excellence. Antimicrobial Stewardship: Systems and Processes for Effective Antimicrobial Medicine Use; National Institute for Health and Care Excellence: London, UK, 2015.
14. Australian Commission on Safety and Quality in Health Care. Antimicrobial Stewardship in Australian Hospitals; Duguid, M., Cruickshank, M., Eds.; Australian Commission on Safety and Quality in health Care: Sydney, Australia, 2011.
15. Patel, D.; Lawson, W.; Guglielmo, B. J. Antimicrobial stewardship programs: Interventions and associated outcomes. Exp. Rev. Anti-infect. Ther. 2008, 6, 209-222. [CrossRef] [PubMed].
16. Nathwani, D.; Gray, K.; Borland, H. Quality indicators for antibiotic control program. J. Hosp. Infect. 2002, 50, 165-169. [CrossRef] [PubMed].
17. Chen, A.; Khumra, S.; Eaton, V.; Kong, D. Snapshot of barriers to and indicators for antimicrobial stewardship in australian hospitals. J. Pharm. Pract. Res. 2011, 41, 37-41. [CrossRef].
18. Morris, A.; Brener, S.; Dresser, L.; Daneman, N.; Dellit, T.; Edina, A.; Chaim, B. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect. Control Hosp. Epidemiol. 2012, 33, 500-506. [CrossRef] [PubMed].
19. Bumpass, J.; McDaneld, P.; DePestel, D. Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists. Clin. Infect. Dis. 2014, 59, S108-S111. [CrossRef] [PubMed].
20. Almirante, B.; Garnacho-Montero, J.; Pachón, J.; Pascual, Á.; Rodríguez-Baño, J. Scientific evidence and research in antimicrobial stewardship. Enferm. Infecc. Microbiol. Clin. 2013, 31, 56-61. [CrossRef].
21. Mercer, K.; Chintalapudi, S.; Visconti, E. Impact of Targeted Antibiotic Restriction on Usage and Cost in a Community Hospital. J. Pharm. Technol. 1999, 15, 79-84.
22. Bassetti, M.; Biagio, A.; Rebesco, B.; Cenderello, G.; Amalfitano, M.; Bassetti, D. Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy. Int. J. Antimicrob. Agents 2000, 16, 295-299. [CrossRef].
23. Berild, D.; Ringertz, S.; Lelek, M.; Fosse, B. Antibiotic guidelines lead to reductions in the use and cost of antibiotics in a University Hospital. Scand. J. Infect. Dis. 2001, 33, 63-67. [PubMed].
24. Ansari, F.; Gray, K.; Nathwani, D.; Phillips, G.; Ogston, S.; Ramsay, C.; Davey, P. Outcomes of an intervention to improve hospital antibiotic prescribing: Interrupted time series with segmented regression analysis. J. Antimicrob. Chemother. 2003, 52, 842-848. [CrossRef] [PubMed].
25. Cook, P.; Catrou, P.; Christie, J.; Young, P.; Polk, R. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J. Antimicrob. Chemother. 2004, 53, 853-859. [CrossRef] [PubMed].
26. Mcgregor, J.; Weekes, E.; Standiford, H.; Forrest, G.; Perencevich, E.; Furuno, J.; Harris, A. Impact of a Computerized Clinical Decision Support System on Reducing Inappropriate Antimicrobial Use: A Randomized Controlled Trial. J. Am. Med. Inf. Assoc. 2006, 13, 378-384. [CrossRef] [PubMed].
27. Siddiqui, S.; Hussein, K.; Manasia, R.; Samad, A.; Salahuddin, N.; Zafar, A.; Hoda, M. Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country. J. Pak. Med. Assoc. 2007, 57, 484-487. [PubMed].
28. Cheng, V.; To, K.; Li, I.; Tang, B.; Chan, J.; Kwan, S.; Mak, R.; Tai, J.; Ching, P.; Ho, P.; Seto, W. Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28, 1447-1456. [CrossRef] [PubMed].
29. Teo, J.; Kwa, A.; Loh, J.; Chlebicki, M.; Lee, W. The effect of a whole-system approach in an antimicrobial stewardship program at the Singapore General Hospital. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31, 947-955. [CrossRef] [PubMed].
30. Michael, K.; Mahdavi, M.; Krug, A.; Kuper, K. Implementation of an Antimicrobial Stewardship Program in a Community Hospital: Results of a Three-Year Analysis. Hosp. Pharm. 2012, 47, 608-616. [CrossRef].
31. Hagert, B.; Williams, C.; Wieser, C.; Rohrich, M.; Shien Lo, T.; Newman, W.; Koo, J. Implementation and Outcome Assessment of an Inpatient Antimicrobial Stewardship Program. Hosp. Pharm. 2012, 47, 939-945. [CrossRef].
32. Vettese, N.; Hendershot, J.; Irvine, M.; Wimer, S.; Chamberlain, D.; Massoud, N. Outcomes associated with a thrice-weekly antimicrobial stewardship program in a 253-bed community hospital. J. Clin. Pharm. Ther. 2013, 38, 401-404. [CrossRef] [PubMed].
33. Cisneros, J.; Neth, O.; Gil-Navarro, M.; Lepe, J.; Jiménez-Parrilla, F.; Cordero, E.; Rodríguez-Hernández, M.; Amaya-Villar, R.; Cano, J.; Gutiérrez-Pizarraya, A.; et al. Global impact of an educational antimicrobial stewardship program on prescribing practice in a tertiary hospital centre. Clin. Microbiol. Infect. 2014, 20, 82-88. [CrossRef] [PubMed].
34. Borde, J.; Kaier, K.; Steib-Bauert, M.; Vach, W.; Geibel-Zehender, A.; Busch, H.; Bertz, H.; Hug, M.; deWith, K.; Kern, W. Feasibility and impact of an intensified antibiotic stewardship program targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. BMC Infect. Dis. 2014, 14, 201. [CrossRef] [PubMed].
35. Bartlett, J.; Siola, P. Implementation and first-year results of an antimicrobial stewardship program at a community hospital. Am. J. Health-Syst. Pharm. 2014, 71, 943-949. [CrossRef] [PubMed].
36. Hou, D.; Wang, Q.; Jiang, C.; Tian, C.; Li, H.; Ji, B. Evaluation of the Short-Term Effects of Antimicrobial Stewardship in the Intensive Care Unit at a Tertiary Hospital in China. PLoS ONE 2014, 9, e101447. [CrossRef] [PubMed].
37. Palmay, L.; Elligsen, M.; Walker, S. Hospital-wide Rollout of Antimicrobial Stewardship: A Stepped-Wedge Randomized Trial. Clin. Infect. Dis. 2014, 59, 867-874. [CrossRef] [PubMed].
38. Chandy, S.; Naik, G.; Charles, R.; Jeyaseelan, V.; Naumova, E.; Thomas, K.; Lundborg, C. The Impact of Policy Guidelines on Hospital Antibiotic Use over a Decade: A Segmented Time Series Analysis. PLoS ONE 2014, 9, e92206. [CrossRef] [PubMed].
39. Fukuda, T.; Watanabe, H.; Ido, S.; Shiragami, M. Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds-Before-after comparative two-year trial in Japan. J. Pharm. Policy Pract. 2014, 7, 10. [CrossRef] [PubMed].
40. Cook, P.; Gooch, M. Long-term effects of an antimicrobial stewardship program at a tertiary-care teaching hospital. Int. J. Antimicrob. Agents 2015, 45, 262-267. [CrossRef] [PubMed].
41. Taggart, L.; Leung, E.; Muller, M.; Matukas, L.; Daneman, N. Differential outcome of an antimicrobial stewardship audit and feedback program in two intensive care units: A controlled interrupted time series study. BMC Infect. Dis. 2015, 15, 480. [CrossRef] [PubMed].
42. McNulty, C.; Logan, M.; Donald, I.; Ennis, D.; Taylor, D.; Baldwin, R.; Bannerjee, M.; Cartwright, K. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J. Antimicrob. Chemother. 1997, 40, 707-711. [CrossRef] [PubMed].
43. Carling, P.; Fung, T.; Killion, A.; Terrin, N.; Barza, M. Favourable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect. Control Hosp. Epidemiol. 2003, 24, 699-706. [CrossRef] [PubMed].
44. Khan, R.; Cheesbrough, J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. J. Hosp. Infect. 2003, 54, 104-108. [CrossRef].
45. Saizy-Callaert, S.; Causse, R.; Furhman, C.; Le Paih, M.; Thébault, A.; Chouaïd, C. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J. Hosp. Infect. 2003, 53, 177-182. [CrossRef] [PubMed].
46. Bantar, C.; Sartori, B.; Vesco, E.; Heft, C.; Saúl, M.; Salamone, F.; Oliva, M. A hospital wide intervention program to optimize the quality of antibiotic use: Impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin. Infect. Dis. 2003, 37, 180-186. [CrossRef] [PubMed].
47. Martin, C.; Ofotokun, I.; Rapp, R.; Empey, K.; Armitstead, J.; Pomeroy, C.; Hoven, A.; Evans, M. Results of an antimicrobial control program at a university hospital. Am. J. Health-Syst. Pharm. 2005, 62, 732-738. [PubMed].
48. Brahmi, N.; Blel, Y.; Kouraichi, N.; Lahdhiri, S.; Thabet, H.; Hedhili, A.; Amamou, M. Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit. J. Infect. Chemother. 2006, 12, 190-194. [CrossRef] [PubMed].
49. Ntagiopoulos, P. G.; Paramythiotou, E.; Antoniadou, A.; Giamarellou, H.; Karabinis, A. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece. Int. J. Antimicrob. Agents 2007, 30, 360-365. [CrossRef] [PubMed].
50. Mach, R.; Vlcek, J.; Prusova, M.; Batka, P.; Rysavy, V.; Kubena, A. Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital. Pharm. World Sci. 2007, 29, 565-572. [CrossRef] [PubMed].
51. Fowler, S.; Webber, A.; Cooper, B.; Phimister, A.; Price, K.; Carter, Y.; Kibbler, C.; Simpson, A.; Stone, S. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: A controlled interrupted time series. J. Antimicrob. Chemother. 2007, 59, 990-995. [CrossRef] [PubMed].
52. Valiquette, L.; Cossette, B.; Garant, M.; Diab, H.; Pépin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin. Infect. Dis. 2007, 45, S112-S121. [CrossRef] [PubMed].
53. Ozorowski, T.; Kawalec, M.; Zaleska, M.; Konopka, L.; Hryniewicz, W. The effect of an antibiotic policy on the control of vancomycin-resistant enterococci outbreak and on the resistance patterns of bacteria isolated from the blood of patients in a hematology unit. Polskie Archiwum Medycyny Wewnetrznej 2009, 119, 712-718. [PubMed].
54. Talpaert, M.; Rao, G.; Cooper, B.; Wade, P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J. Antimicrob. Chemother. 2011, 66, 2168-2174. [CrossRef] [PubMed].
55. Altunsoy, A.; Cenk, A.; Alpay, A.; Önder, E.; İsmail, B. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int. J. Med. Sci. 2011, 8, 339-344. [CrossRef] [PubMed].
56. Cook, P.; Shemra, R.; Michael, G.; Jordan, M.; Fang, X.; Hudson, S. Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital. J. Antimicrob. Chemother. 2011, 66, 205-209. [CrossRef] [PubMed].
57. Niwa, T.; Shinoda, Y.; Suzuki, A.; Ohmori, T.; Yasuda, M.; Ohta, H.; Fukao, A.; Kitaichi, K.; Matsuura, K.; Sugiyama, T.; et al. Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital. Int. J. Clin. Pract. 2012, 66, 999-1008. [CrossRef] [PubMed].
58. Aldeyab, M.; Kearney, M.; Scott, M.; Aldiab, M.; Alahmadi, Y.; Elhajji, F. D.; Magee, F.; McElnay, J. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J. Antimicrob. Chemother. 2012, 6, 12. [CrossRef] [PubMed].
59. Jaggi, N.; Sissodia, P.; Sharma, L. Impact of antimicrobial stewardship programme on carbapenem resistance in gram negative isolates in an Indian tertiary care hospital. Am. J. Infect. Dis. 2012, 8, 106-111.
60. Sarraf-Yazdi, S.; Sharpe, M.; Bennett, K.; Dotson, T.; Anderson, D.; Vaslef, S. A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit. J. Surg. Res. 2012, 176, E73-E78. [CrossRef] [PubMed].
61. Nowak, M.; Nelson, R.; Breidenbach, J.; Thompson, P.; Carson, P. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am. J. Health-Syst. Pharm. 2012, 69, 1500-1508. [CrossRef] [PubMed].
62. Malani, A.; Richards, P.; Kapila, S.; Otto, M.; Czerwinski, J.; Singal, B. Clinical and economic outcomes from a community hospital's antimicrobial stewardship program. Am. J. Infect. Control 2013, 41, 145-148. [CrossRef] [PubMed].
63. Dancer, S.; Kirkpatrick, P.; Corcoran, D.; Christison, F.; Farmer, D.; Robertson, C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, methicillin-resistant Staphylococcus aureus and extended-Spectrum beta-lactamase producing coliforms in a district general hospital. Int. J. Antimicrob. Agents 2013, 41, 137-142. [CrossRef] [PubMed].
64. Wenisch, J.; Equiluz-Bruck, S.; Fudel, M.; Reiter, I.; Schmid, A.; Singer, E.; Chott, A. Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use. Antimicrob. Agents Chemother. 2014, 58, 5079-5083. [CrossRef] [PubMed].
65. Knudsen, J.; Andersen, S. A multidisciplinary intervention to reduce infections of ESBL-And AmpC-producing, Gram-negative bacteria at a university hospital. PLoS ONE 2014, 9, e86457. [CrossRef] [PubMed].
66. Sarma, J.; Marshall, B.; Cleeve, V.; Tate, D.; Oswald, T.; Woolfrey, S. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis. J. Hosp. Infect. 2015, 91, 74-80. [CrossRef] [PubMed].
67. Bartlett, J. A call to arms: The imperative for antimicrobial stewardship. Clin. Infect. Dis. 2011, 53, S4-S7. [CrossRef] [PubMed].
68. Gums, J.; Yancey, R.; Hamilton, C.; Kubilis, P. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 1999, 19, 1369-1377. [CrossRef] [PubMed].
69. Chang, M.; Wu, T.; Wang, C.; Jang, T.; Huang, C. The impact of an intensive antimicrobial control program in a Taiwanese medical center. Pharm. World Sci. 2006, 28, 257-264. [CrossRef] [PubMed].
70. Ng, C.; Wu, C.; Chan, W.; Leung, Y.; Li, C.; Tsang, D.; Leung, G. Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong. Qual. Safety Health Care 2008, 17, 387-392. [CrossRef] [PubMed].
71. Chan, Y.; Lin, T.; Huang, C.; Deng, S.; Wu, T.; Leu, H.; Chiu, C. Implementation and outcomes of a hospital-wide computerised antimicrobial stewardship program in a large medical centre in Taiwan. Int. J. Antimicrob. Agents 2011, 38, 486-492. [CrossRef] [PubMed].
72. Liew, Y.; Lee, W.; Loh, J.; Cai, Y.; Tang, S.; Lim, C.; Teo, J.; Ong, R.; Kwa, A.; Chlebicki, M. Impact of an antimicrobial stewardship program on patient safety in Singapore General Hospital. Int. J. Antimicrob. Agents 2012, 40, 55-60. [CrossRef] [PubMed].
73. DiazGranados, C. Prospective audit for antimicrobial stewardship in intensive care: Impact on resistance and clinical outcomes. Am. J. Infect. Control 2012, 40, 526-529. [CrossRef] [PubMed].
74. Rimawi, R.; Mazer, M.; Siraj, D.; Gooch, M.; Cook, P. Impact of Regular Collaboration between Infectious Diseases and Critical Care Practitioners on Antimicrobial Utilization and Patient Outcome. Crit. Care Med. 2013, 41, 2099-2107. [CrossRef] [PubMed].
75. Lin, Y.; Lin, I.; Yen, F.; Lin, P.; Shiu, Y.; Hu, H.; Yang, Y. Impact of an antimicrobial stewardship program with multidisciplinary cooperation in a community public teaching hospital in Taiwan. Am. J. Infect. Control 2013, 41, 1069-1072. [CrossRef] [PubMed].
76. Tsukamoto, H.; Higashi, T.; Nakamura, T. Clinical effect of a multidisciplinary team approach to the initial treatment of patients with hospital-acquired bloodstream infections at a Japanese university hospital. Am. J. Infect. Control 2014, 42, 970-975. [CrossRef] [PubMed].
77. Pasquale, T.; Trienski, T.; Olexia, D.; Myers, J.; Tan, M.; Leung, A.; Poblete, J.; File, T., Jr. Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections. Am. J. Health-Syst. Pharm. 2014, 71, 1136-1139. [CrossRef] [PubMed].
78. Rosa, R.; Goldani, L.; dos Santos, R. Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: A prospective cohort study. BMC Infect. Dis. 2014, 14, 286. [CrossRef] [PubMed].
79. Lew, K.; Ng, T.; Tan, M.; Tan, S.; Lew, E.; Ling, L.; Ang, B.; Lye, D.; Teng, C. Safety and Clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship program in an ESBL-endemic setting. J. Antimicrob. Chemother. 2015, 70, 1219-1225. [PubMed].
80. Okumura, L.; da Silva, M.; Veroneze, I. Effects of a bundled Antimicrobial Stewardship Program on mortality: A cohort study. Braz. J. Infect. Dis. 2015, 19, 246-252. [CrossRef] [PubMed].
81. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment; WHO Collaborating Centre for Drug Statistics Methodology: Oslo, Norway, 2012.
82. Septimus, E. Antimicrobial Stewardship-Qualitative and Quantitative Outcomes: The role of measurement. Curr. Infect. Dis. Rep. 2014, 16, 433. [CrossRef] [PubMed].
83. MacDougall, C.; Polk, R. Antimicrobial stewardship programs in health care systems. Clin. Microbiol. Rev. 2005, 18, 638-656. [CrossRef] [PubMed].
84. Fishman, N.; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America and Pediatric Infectious Diseases Society. Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect. Control Hosp. Epidemiol. 2012, 33, 322-327.
85. Aldeyab, M.; McElnay, C.; Scott, M.; Lattyak, W.; Darwish Elhajji, F. W.; Aldiab, M.; Magee, F.; Conlon, G.; Kearney, M. A modified method for measuring antibiotic use in healthcare settings: Implications for antibiotic stewardship and benchmarking. J. Antimicrob. Chemother. 2014, 69, 1132-1141. [CrossRef] [PubMed].
86. Polk, R.; Fox, C.; Mahoney, A.; Letcavage, J.; MacDougall, C. Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy. Clin. Infect. Dis. 2007, 44, 664-670. [CrossRef] [PubMed].
87. Dodds Ashley, E. S.; Kaye, K.; DePestel, D.; Hermsen, E. Antimicrobial Stewardship: Philosophy versus Practice. Clin. Infect. Dis. 2014, 59, S112-S121. [CrossRef] [PubMed].
88. Pakyz, A.; Moczygemba, L.; vander Wielen, L.; Edmond, M.; Stevens, M.; Kuzel, A. Facilitators and barriers to implementing antimicrobial strategies: Results from a qualitative study. Am. J. Infect. Control 2014, 42, S257-S263. [CrossRef] [PubMed].